Workflow
Unicycive(UNCY) - 2024 Q2 - Quarterly Results
UNCYUnicycive(UNCY)2024-08-14 12:11

Exhibit 99.1 Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update – On Track to Submit OLC New Drug Application (NDA) by End of August 2024 – LOS ALTOS, Calif., August 14, 2024 – Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the "Company" or "Unicycive"), a clinicalstage biotechnology company developing therapies for patients with kidney disease, today announced its financial results for the three months ended June 30, 2024, and provided a business update. "Achieving success ...